2-[3-fluoro-2-(propan-2-yl)phenyl]-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-8,9-dihydro-7H-purin-8-one
Structure Info
- Chemspace ID
- CSSB06741697637 (In-Stock Building Blocks)
- CAS
- 2098212-05-4
- MFCD
- MFCD00824427, MFCD34676775
- IUPAC Name
- 2-[3-fluoro-2-(propan-2-yl)phenyl]-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-8,9-dihydro-7H-purin-8-one
- Mol formula
- C26H22F4N6O
- Mol weight
- 510 Da
- Catalog Number(s)
- AA027HXZ, AD265241, AG027I0R, AR027IPR, BD01581925, BL08979, BUP09403, EC027K6J, H53902, HY-148099, MS-29474, ST027JHJ, T63518, TX027J6F, Y3164149, ZXC345389
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 7.1
- Heavy atoms count
- 37
- Rotatable bond count
- 6
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.23076923076923
- Polar surface area (Å)
- 76
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of 2-[3-fluoro-2-(propan-2-yl)phenyl]-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-8,9-dihydro-7H-purin-8-one (C26H22F4N6O) - CSSB06741697637](/st/structure/200/24c9e061263795016a0135153692b1c0/CC%2528C%2529c1c%2528F%2529cccc1-c1ncc2%255BnH%255Dc%2528%253DO%2529n%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png "C26H22F4N6O")
- Zoom the structure
- CSSB06741697637
Items Overall 38 items from 10 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Advanced ChemBlocks CN | 3 days | China To: | 98 | 1 mg | 350.00 | |
| Advanced ChemBlocks CN | 3 days | China To: | 98 | 5 mg | 865.00 | |
| Advanced ChemBlocks CN | 3 days | China To: | 98 | 25 mg | 1,740.00 | |
| Advanced ChemBlocks CN | 3 days | China To: | 98 | 100 mg | 3,080.00 | |
Description: USP1-IN-2; CAS: 2098212-05-4 | ||||||
| 1st Scientific LLC | 7 days | United States To: | 90 | 1 mg | 389.40 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 5 mg | 885.50 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 10 mg | 1,153.90 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 25 mg | 1,729.20 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 50 mg | 2,569.60 | |
| 1st Scientific LLC | 7 days | United States To: | 90 | 100 mg | 3,328.60 | |
Description: 2-[3-Fluoro-2-(1-methylethyl)phenyl]-7,9-dihydro-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one; CAS: 2098212-05-4 | ||||||
| Angene International Limited | 10 days | China To: | 95 | 5 mg | 321.30 | |
| Angene International Limited | 10 days | China To: | 95 | 10 mg | 457.20 | |
| Angene International Limited | 10 days | China To: | 95 | 25 mg | 680.40 | |
| Angene International Limited | 10 days | China To: | 95 | 50 mg | 917.10 | |
Description: 2-[3-Fluoro-2-(1-methylethyl)phenyl]-7,9-dihydro-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one; CAS: 2098212-05-4 | ||||||
| Advanced ChemBlock Inc | 10 days | United States To: | 98 | 1 mg | 350.00 | |
| Advanced ChemBlock Inc | 10 days | United States To: | 98 | 5 mg | 865.00 | |
| Advanced ChemBlock Inc | 10 days | United States To: | 98 | 25 mg | 1,740.00 | |
| Advanced ChemBlock Inc | 10 days | United States To: | 98 | 100 mg | 3,080.00 | |
Description: USP1-IN-2; CAS: 2098212-05-4 | ||||||
| Astatech CN | 10 days | China To: | 95 | 10 mg | 1,175.90 | |
Description: USP1-IN-2; CAS: 2098212-05-4 | ||||||
| AA BLOCKS | 12 days | United States To: | 90 | 1 mg | 196.90 | |
| AA BLOCKS | 12 days | United States To: | 90 | 5 mg | 448.80 | |
| AA BLOCKS | 12 days | United States To: | 90 | 10 mg | 584.10 | |
| AA BLOCKS | 12 days | United States To: | 90 | 25 mg | 875.60 | |
| AA BLOCKS | 12 days | United States To: | 90 | 50 mg | 1,169.30 | |
| AA BLOCKS | 12 days | United States To: | 90 | 100 mg | 1,569.70 | |
Description: 2-[3-Fluoro-2-(1-methylethyl)phenyl]-7,9-dihydro-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one; CAS: 2098212-05-4 | ||||||
| A2B Chem | 12 days | United States To: | 99 | 1 mg | 288.65 | |
| A2B Chem | 12 days | United States To: | 99 | 5 mg | 710.70 | |
| A2B Chem | 12 days | United States To: | 99 | 10 mg | 938.40 | |
| A2B Chem | 12 days | United States To: | 99 | 25 mg | 1,427.15 | |
Description: 2-[3-Fluoro-2-(1-methylethyl)phenyl]-7,9-dihydro-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one; CAS: 2098212-05-4 | ||||||
| eNovation CN | 20 days | China To: | 99 | 10 mg | 1,098.25 | |
| eNovation CN | 20 days | China To: | 99 | 25 mg | 1,788.25 | |
Description: 2-[3-Fluoro-2-(1-methylethyl)phenyl]-7,9-dihydro-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one; CAS: 2098212-05-4 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 95 | 10 mg | 1,397.00 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 25 mg | 2,326.50 | |
Description: 2-[3-Fluoro-2-(1-methylethyl)phenyl]-7,9-dihydro-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one; CAS: 2098212-05-4 | ||||||
| 10X CHEM | TBD | United States To: | 90 | 1 mg | 229.90 | |
| 10X CHEM | TBD | United States To: | 90 | 5 mg | 566.50 | |
| 10X CHEM | TBD | United States To: | 90 | 10 mg | 748.00 | |
| 10X CHEM | TBD | United States To: | 90 | 25 mg | 1,137.40 | |
| 10X CHEM | TBD | United States To: | 90 | 100 mg | 3,434.20 | |
Description: 2-[3-Fluoro-2-(1-methylethyl)phenyl]-7,9-dihydro-9-[[4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-8H-purin-8-one; CAS: 2098212-05-4 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-2-[2-(propan-2-yl)phenyl]-8,9-dihydro-7H-purin-8-one - CSSB14823689088](/st/structure/200/6eca3064260074fc9a4bb7a57a9b231a/CC%2528C%2529c1ccccc1-c1ncc2%255BnH%255Dc%2528%253DO%2529n%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
![Chemical structure of 2-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-9-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-7H-purin-8-imine - CSSB20465146705](/st/structure/200/7abb0bf6a13e192b4250c8ad8e2f0a66/COC1%253DNC%253DNC%2528C2CC2%2529%253DC1C1%253DNC%253DC2N%2528CC%2528F%2529%2528F%2529F%2529C%2528%253DN%2529N%2528CC3%253DCC%253DC%2528C%253DC3%2529C3%253DNC%2528%253DCN3C%2529C%2528F%2529%2528F%2529F%2529C2%253DN1.png)
![Chemical structure of 4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]benzoic acid - CSSB17194914666](/st/structure/200/fb465665f1407cf7d5d15f1be7fe9b34/CN1C%253DC%2528N%253DC1C1%253DCC%253DC%2528C%253DC1%2529C%2528O%2529%253DO%2529C%2528F%2529%2528F%2529F.png)
![Chemical structure of 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-7-fluoro-3-methyl-1-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-1H,2H,3H-imidazo[4,5-c]pyridin-2-one - CSSB17764111963](/st/structure/200/e240f44f2efc3f0afd561dab23987cf9/COC1%253DNC%253DNC%2528C2CC2%2529%253DC1C1%253DNC%253DC2N%2528C%2529C%2528%253DO%2529N%2528CC3%253DCC%253DC%2528C%253DC3%2529C3%253DNC%2528%253DCN3C%2529C%2528F%2529%2528F%2529F%2529C2%253DC1F.png)
![Chemical structure of 4-cyclopropyl-6-methoxy-5-[7-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl]pyrimidine - CSSB14823689089](/st/structure/200/f03e9d6cfb6b613a09a47464d4602a35/COc1ncnc%2528C2CC2%2529c1-c1ncc2%255BnH%255Dcc%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
![Chemical structure of 4-cyclopropyl-6-methoxy-5-[5-methyl-7-({4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl}methyl)-5H-pyrrolo[3,2-d]pyrimidin-2-yl]pyrimidine - CSSB06741706377](/st/structure/200/963826454f8b8a2f157e9f4b3f84c2cc/COc1ncnc%2528C2CC2%2529c1-c1ncc2n%2528C%2529cc%2528Cc3ccc%2528cc3%2529-c3nc%2528cn3C%2529C%2528F%2529%2528F%2529F%2529c2n1.png)
![Chemical structure of 3-fluoro-4-[1-methyl-4-(trifluoromethyl)-1H-imidazol-2-yl]benzonitrile - CSSB20504706261](/st/structure/200/233df3073bf75ee2c2622f10b57cfec9/CN1C%253DC%2528N%253DC1C1%253DCC%253DC%2528C%253DC1F%2529C%2523N%2529C%2528F%2529%2528F%2529F.png)
